Exosome provides a new intervention target for atherosclerosis
Author:
Affiliation:

Institute of Cardiovascular Disease Research & Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan 421001, China)

Clc Number:

R363

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Atherosclerosis is a chronic inflammatory disease. The objective of the clinical use of anti-atherosclerotic drugs is to decrease circulating low density lipoprotein level, increase high density lipoprotein level, and reduce inflammation. However, the morbidity and mortality of cardiovascular disease remain high. Therefore, the identification of unknown therapeutic targets and the development of new anti-atherosclerotic drugs is growing. Exosome is a kind of membrane vesicles derived from late nuclear endosome (also known as polycystic body) secreted by living cells. Exosome contains protein, rRNA, and micro RNA, which are related to the source cells, and it can pass the biological barrier and produce various biological functions. Exosome is expected to become a novel drug delivery pathway and gene therapy vector for the treatment of atherosclerosis.

    Reference
    Related
    Cited by
Get Citation

JIANG Yue, TIAN Meng-Xiang, WANG Shuang, YI Guang-Hui. Exosome provides a new intervention target for atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(4):411-416.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 17,2016
  • Revised:November 03,2016
  • Online: May 18,2017
Article QR Code